Pharmacological inactivation of MYC for the treatment of cancer

被引：17

作者：

Felsher, DW ^{[1
]}

Bradon, N

机构：

[1] Stanford Univ, Dept Med, Div Oncol, Stanford, CA 94305 USA

[2] Stanford Univ, Dept Pathol, Div Oncol, Stanford, CA 94305 USA

来源：

DRUG NEWS & PERSPECTIVES | 2003年 / 16卷 / 06期

关键词：

CHRONIC MYELOID-LEUKEMIA; ABL TYROSINE KINASE; C-MYC; ANTISENSE OLIGONUCLEOTIDE; NEOPLASTIC PHENOTYPE; GENOMIC INSTABILITY; SMALL-MOLECULE; CELLS; INHIBITOR; TUMORIGENESIS;

D O I：

10.1358/dnp.2003.16.6.829309

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The overexpression of the MYC proto-oncogene has been implicated in the pathogenesis of most types of human cancer. Recent experimental observations indicate that the inactivation of MYC may be effective in the treatment of neoplasia. Several different strategies have been employed to develop novel drugs that may be effective to target the inactivation of MYC for the treatment of cancer. Some of these strategies are discussed. (C) 2003 Prous Science. All rights reserved.

引用

页码：370 / 374

页数：5

共 37 条

[21] Sustained loss of a neoplastic phenotype by brief inactivation of MYC [J].

Jain, M ;

Arvanitis, C ;

Chu, K ;

Dewey, W ;

Leonhardt, E ;

Trinh, M ;

Sundberg, CD ;

Bishop, JM ;

Felsher, DW .

SCIENCE, 2002, 297 (5578) :102-104

[22] Genomically complex lymphomas undergo sustained tumor regression upon MYC inactivation unless they acquire novel chromosomal translocations [J].

Karlsson, Å ;

Giuriato, S ;

Tang, F ;

Fung-Weier, J ;

Levan, G ;

Felsher, DW .

BLOOD, 2003, 101 (07) :2797-2803

[23] Resistance to chemotherapeutic drugs overcome by c-Myc inhibition in a Lewis lung carcinoma murine model [J].

Knapp, DC ;

Mata, JE ;

Reddy, MT ;

Devi, GR ;

Iversen, PL .

ANTI-CANCER DRUGS, 2003, 14 (01) :39-47

[24]

KOSKINEN PJ, 1995, CELL GROWTH DIFFER, V6, P623

[25]

Li Q, 1999, MOL CELL BIOL, V19, P5339

[26]

Mai S, 1996, ONCOGENE, V12, P277

[27] Genomic instability in MycER-activated Rat1A-MycER cells [J].

Mai, S ;

Fluri, M ;

Siwarski, D ;

Huppi, K .

CHROMOSOME RESEARCH, 1996, 4 (05) :365-371

[28]

Mani S, 2002, CLIN CANCER RES, V8, P1042

[29] MYC FUNCTION AND REGULATION [J].

MARCU, KB ;

BOSSONE, SA ;

PATEL, AJ .

ANNUAL REVIEW OF BIOCHEMISTRY, 1992, 61 :809-860

[30] The myc oncogene:: (M)under-bar-arvelousl(Y)under-bar (C)under-bar-omplex [J].

Oster, SK ;

Ho, CSW ;

Soucie, EL ;

Penn, LZ .

ADVANCES IN CANCER RESEARCH, VOL 84, 2002, 84 :81-154

← 1 2 3 4 →